A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1994
11/02/1994	EP0622408A1 Composition and process for gelatin-free soft capsules
11/02/1994	EP0622394A1 Reversible modification of sulfur-containing molecules with polyalkylene glycol derivatives and their use
11/02/1994	EP0622084A1 Antibody-drug conjugates
11/02/1994	EP0622083A1 Taste masked solid preparation and its production
11/02/1994	EP0622082A1 Immunocomplex
11/02/1994	EP0621880A1 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
11/02/1994	EP0621877A1 Esters of pectic and pectinic acid
11/02/1994	EP0621784A1 An iron-containing composition for the prevention of anaemia and a method for producing the composition.
11/02/1994	EP0621777A1 Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies.
11/02/1994	EP0621776A1 Injectable composition containing collagen microcapsules.
11/02/1994	EP0621773A1 Formulation and use of carotenoids in treatment of cancer
11/02/1994	EP0621769A1 Transdermal administration of short or intermediate half-life benzodiazepines
11/02/1994	EP0542855B1 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation
11/02/1994	EP0489068B1 Polymeric materials
11/02/1994	CN1094312A X-ray contrast medium used for checking of large and small intestine
11/02/1994	CN1094284A Novel compositions based on nomegestrol derivatives and the processes for their production
11/01/1994	US5360897 Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
11/01/1994	US5360895 Derivatized gold clusters and antibody-gold cluster conjugates
11/01/1994	US5360615 Solvent system enhancing the solubility of pharmaceuticals for encapsulation
11/01/1994	US5360610 Method for stimulating nerve fiber growth
11/01/1994	US5360605 Preservation of blood, tissues and biological fluids
11/01/1994	CA1332809C Sustained release pharmaceutical compositions
11/01/1994	CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/29/1994	CA2122286A1 Solid preparation and its production
10/29/1994	CA2121990A1 Antibody-drug conjugates
10/28/1994	WO1993022370A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy
10/28/1994	CA2134346A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy
10/28/1994	CA2121555A1 Composition and process for gelatin-free soft capsules
10/27/1994	WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
10/27/1994	WO1994024158A1 Cellulose binding domain
10/27/1994	WO1994024145A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	WO1994023832A1 Use of a transacylation reaction between an esterified polysaccharide and a polyamine to form a membrane at least on the surface of gelled particles in an aqueous medium, resulting particles, preparation methods therefor and compositions containing same
10/27/1994	WO1994023767A1 Oral drug delivery compositions and methods
10/27/1994	WO1994023759A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	WO1994023753A1 Cancer therapy, using antibody conjugates, in combination with a vasoactive agent
10/27/1994	WO1994023752A1 Drug delivery system
10/27/1994	WO1994023751A1 Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
10/27/1994	WO1994023750A1 Reversible, thermally gelling water-base medicinal composition
10/27/1994	WO1994023743A1 Method and compositions for digesting tissue
10/27/1994	WO1994023738A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
10/27/1994	WO1994023733A1 New cyclosporine-containing pharmaceutical compositions for oral administration
10/27/1994	WO1994023725A1 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
10/27/1994	WO1994023713A1 Transdermal antiinflammatory composition
10/27/1994	WO1994023711A1 Stable ketamine solutions
10/27/1994	WO1994023707A1 Active substance-containing plaster
10/27/1994	WO1994023703A1 Manufacturing matrices
10/27/1994	WO1994023702A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
10/27/1994	WO1994023701A1 Particulate vector and pharmaceutical composition containing such vector
10/27/1994	WO1994023699A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
10/27/1994	WO1994023697A1 Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
10/27/1994	WO1994023688A2 Cosmetic and medicinal topical preparations
10/27/1994	WO1994023649A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/27/1994	WO1994023581A1 Iodine barrier teat dip
10/27/1994	CA2161143A1 New pharmaceutical preparations comprising cyclosporin for oral administration
10/27/1994	CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo
10/27/1994	CA2161121A1 Particulate vector and pharmaceutical composition containing the same
10/27/1994	CA2161109A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	CA2160878A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
10/27/1994	CA2160877A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
10/27/1994	CA2160692A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
10/27/1994	CA2160670A1 Cellulose binding domain
10/27/1994	CA2160532A1 Method and compositions for digesting tissue
10/27/1994	CA2160370A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	CA2159799A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/27/1994	CA2154356A1 Iodine barrier teat dip
10/26/1994	EP0621287A1 Cyclodextrin-biocide complex
10/26/1994	EP0621263A2 External anti-inflammatory and analgesic plaster preparation
10/26/1994	EP0621073A1 Method to increase the stability of nanocapsules during storage thereof
10/26/1994	EP0621036A1 Aqueous compositions comprising argatroban and cyclodextrin or caffeine
10/26/1994	EP0621033A1 Antibiotic composition containing oxytetracycline and glycofurol
10/26/1994	EP0621031A2 Ointment for wound treatment
10/26/1994	EP0620828A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
10/26/1994	EP0620743A1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid
10/26/1994	EP0620742A1 Inactivation of cytotoxic drugs
10/26/1994	EP0620741A1 Cytotoxic drug therapy
10/26/1994	EP0620740A1 Injectable lecithin gel
10/26/1994	EP0620733A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
10/26/1994	EP0620731A1 Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it.
10/26/1994	EP0620727A1 Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets.
10/26/1994	EP0192667B1 Device for initiating reperfusion treatment when heart attack symptoms are present
10/26/1994	CN1094054A Desiccant, dehydration therewith, and dehydrated product obtainable threby
10/26/1994	CN1093901A Stable pharmaceutical composition of fumagillol derivatives
10/26/1994	CN1093897A Production method for surface anesthesia film
10/25/1994	US5359086 Process for preparing alkyl-L-alanyl-L-proline derivatives
10/25/1994	US5359030 Coupling of a peptide and polymer; therapy, diagnosis
10/25/1994	US5358970 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
10/25/1994	US5358941 Dry mix formulation for bisphosphonic acids with lactose
10/25/1994	US5358931 Interaction of thermal hysteresis proteins with cells and cell membranes and associated applications
10/25/1994	US5358722 Ferritin analogs
10/25/1994	US5358715 Molsidomine drug
10/25/1994	US5358710 Administering an immunosuppressant amount of a tolerogenic conjugate of an antigenic polypeptide covalently bound to a water soluble polymer
10/25/1994	US5358706 Muco-adhesive polymers
10/25/1994	US5358502 PH-triggered osmotic bursting delivery devices
10/25/1994	CA1332713C Skin penetration enhancement using free base and acid addition salt combinations of active agents
10/25/1994	CA1332712C Intravenous pharmaceutical composition
10/23/1994	CA2121723A1 Aqueous agent
10/19/1994	EP0620012A1 X-ray contrast medium for examining large and small intestines
10/19/1994	EP0620011A1 Antibody-drug conjugates
10/19/1994	EP0619802A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
10/19/1994	EP0619742A1 Transfection of lung via aerosolized transgene delivery

1 ... 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 ... 1712